compounded semaglutide fda approved Approval vs Alternatives FDA ends semaglutide shortage, closing

(Source) Gallbladder problems: One survey study found that patients who took a semaglutide, like Ozempic, were significantly more likely to experience pancreatitis, ileus, and gastroparesis than the control group

Drucker had read about the work of endocrinologist John Eng, gastroenterologist Jean-Pierre Raufman and biochemist John Pisano, who had sequenced the proteins in Gila monster ( Heloderma suspectum ) venom and found two that looked like human GLP-1

Brouwers B, Rao G, Tang Y et al (2024) Incretin-based investigational therapies for the treatment of MASLD/MASH

who might want to use these products

That 6 lb difference represents meaningful additional progress, especially for those close to goal weight